Analyst firms · Raymond James · ARGX

Raymond James ARGX price target and rating history

argenx SE (ARGX) · Health Care

Raymond James rates argenx SE (ARGX) Strong Buy with a $605 price target, as of its latest action on Oct 10, 2024. It has published 3 rating actions on ARGX since October 2021, including 1 upgrade and 0 downgrades. Across 3 firms with a ARGX price target in the last 12 months, the median target is $1,185.

Current rating
Strong Buy
Price target
$605
Median target, all firms
$1,185
Actions on ARGX
3

Raymond James price target on ARGX

$605$498$39020222023202420252026
Raymond James price target on ARGX, each point a stated target, October 2021 to October 2024.

Every Raymond James rating on ARGX

How other firms rate ARGX

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
UBSBuy$1,400Aug 26, 2026
Deutsche BankHoldAug 24, 2026
GuggenheimBuy$1,185Aug 4, 2026
Robert W. BairdNeutral$858Dec 18, 2025
Wolfe ResearchPeer PerformNov 24, 2025

Questions about Raymond James and ARGX

What is Raymond James's price target for ARGX?
Raymond James's latest stated price target for argenx SE (ARGX) is $605, from its action on Oct 10, 2024.
What is Raymond James's rating on ARGX?
Raymond James rates ARGX Strong Buy, a bullish rating, as of Oct 10, 2024.
When did Raymond James last change its view on ARGX?
On Oct 10, 2024, Raymond James resumes coverage at Strong Buy, price target $605.
How does Raymond James's ARGX target compare with other analysts?
Across 3 firms with a ARGX price target in the last 12 months, the median target is $1,185.

More ARGX rating histories

All Raymond James ratingsARGX news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.